Skip to content

QUALIFY Life Sciences

Active
Private limited companyfounded 20242 yrs activeLouizalaan 251, 1050 Brussel, BelgiumKBO/BCE: BE 1004.523.684
Summary

QUALIFY Life Sciences has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €405k and a net result of €338k. Its solvency ranks better than 31% of 31791 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability100▲+10
Solvency56▲+12
Growth78
Track record82
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days only on tighter terms
Liquidity tight (current ratio 1.4 against 1.91 in 2024; short-term debt: 64.4% and cash: 28% of total assets), and 68.8% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Activities of head offices; management consultancy activities (NACE 70)
about 69% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
31.2%
Return on assets
26.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
1 d early
2024
25 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

QUALIFY Life Sciences was incorporated on 10 January 2024 as a Private limited company.1 The company has filed 2 sets of annual accounts, the latest for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Financials · fiscal year 2025, micro schema

Equity
€405k▲ 505%
2024 · €67k
Total assets
€1.30M▲ 273%
2024 · €347k
Net result
€338k▲ 483%
2024 · €58k
Working capital
€334k▲ 113%
2024 · €157k
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20242025
Operating result€75k-€478k▲ 538%
Net result€58k-€338k▲ 483%
Equity€67k-€405k▲ 505%
Total assets€347k-€1.30M▲ 273%
Debt€281k-€891k▲ 218%
Working capital€157k-€334k▲ 113%
Staff (FTE)3.9-13.6▲ 249%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400kOperating result 2024: €75k€75kNet result 2024: €58k€58kOperating result 2025: €478k€478kNet result 2025: €338k€338k20242025€0€200k€400kOperating result 2024: €75k€75kNet result 2024: €58k€58kOperating result 2025: €478k€478kNet result 2025: €338k€338k20242025
The operating result rises in 2025; 2025 is 538% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.30M
Fixed assets €127k ▲ 588%
Current assets €1.17M ▲ 255%
Equity and liabilities €1.30M
Equity €405k ▲ 505%
Debt €891k ▲ 218%
Debt's share of the balance-sheet total falls from 80.7% to 68.8%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€498k▲
2024 · €77k
Cash flow
€358k▲
2024 · €60k
Current ratio
1.40▼
2024 · 1.91
Debt to equity
2.20▼
2024 · 4.19
ROE
83.5%▼
2024 · 86.5%
ROA
26.1%▲
2024 · 16.7%
Interest coverage
50.91▼
2024 · 71.51
Debt ≤ 1 year
€835k▲
2024 · €172k
Debt > 1 year
€56k▼
2024 · €109k
Income taxes
€131k▲
2024 · €16k
Staff costs
€984k▲
2024 · €125k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€347k€1.30M▲
Fixed assets21/28€18k€127k▲
Tangible fixed assets22/27€17k€121k▲
Plant, machinery and equipment23-€1k
Furniture and vehicles24€13k€112k▲
Other tangible fixed assets26€4k€9k▲
Financial fixed assets28€2k€6k▲
Current assets29/58€329k€1.17M▲
Amounts receivable after more than one year29€25k-
Other amounts receivable291€25k-
Amounts receivable within one year40/41€164k€805k▲
Trade receivables40€164k€805k▲
Cash at bank and in hand54/58€136k€363k▲
Deferred charges and accrued income490/1€4k-
Equity and liabilities
Total equity and liabilities10/49€347k€1.30M▲
Equity10/15€67k€405k▲
Contributions10/11€9k€9k=
Profit (loss) carried forward14€58k€396k▲
Amounts payable17/49€281k€891k▲
Amounts payable after more than one year17€109k€56k▼
Financial debts170/4€109k€56k▼
Amounts payable within one year42/48€172k€835k▲
Current portion of amounts payable after more than one year42-€18k
Trade debts44€100k€420k▲
Suppliers440/4€100k€420k▲
Taxes, remuneration and social security45€69k€394k▲
Taxes450/3€54k€329k▲
Remuneration and social security454/9€14k€65k▲
Other amounts payable47/48€3k€2k▼
Income statement Code20242025
Remuneration, social security and pensions62€125k€984k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€20k▲
Other operating charges640/8€2k€7k▲
Gross operating margin9900€203k€1.49M▲
Operating profit (loss)9901€75k€478k▲
Financial income75/76B€1-
Recurring financial income75€1-
Financial charges65/66B€1k€10k▲
Recurring financial charges65€1k€10k▲
Profit (loss) for the period before taxes9903€74k€469k▲
Income taxes67/77€16k€131k▲
Profit (loss) for the period9904€58k€338k▲
Profit (loss) for the period to be appropriated9905€58k€338k▲
Appropriation of the result
Profit (loss) to be appropriated9906€58k€396k▲
Profit (loss) brought forward from the previous period14P-€58k

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Remuneration, social security and pensions62€125k€984k▲ 691%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€20k▲ 910%
Other operating charges640/8€2k€7k▲ 287%
Gross operating margin9900€203k€1.49M▲ 633%
Operating profit (loss)9901€75k€478k▲ 538%
Financial income75/76B€1--
Recurring financial income75€1--
Financial charges65/66B€1k€10k▲ 810%
Recurring financial charges65€1k€10k▲ 810%
Profit (loss) for the period before taxes9903€74k€469k▲ 534%
Income taxes67/77€16k€131k▲ 718%
Profit (loss) for the period9904€58k€338k▲ 483%
Profit (loss) for the period to be appropriated9905€58k€338k▲ 483%
Line20242025Change
Assets
Total assets20/58€347k€1.30M▲ 273%
Fixed assets21/28€18k€127k▲ 588%
Tangible fixed assets22/27€17k€121k▲ 625%
Plant, machinery and equipment23-€1k-
Furniture and vehicles24€13k€112k▲ 762%
Other tangible fixed assets26€4k€9k▲ 128%
Financial fixed assets28€2k€6k▲ 240%
Current assets29/58€329k€1.17M▲ 255%
Amounts receivable after more than one year29€25k--
Other amounts receivable291€25k--
Amounts receivable within one year40/41€164k€805k▲ 391%
Trade receivables40€164k€805k▲ 391%
Cash at bank and in hand54/58€136k€363k▲ 167%
Deferred charges and accrued income490/1€4k--
Equity and liabilities
Total equity and liabilities10/49€347k€1.30M▲ 273%
Equity10/15€67k€405k▲ 505%
Contributions10/11€9k€9k=
Profit (loss) carried forward14€58k€396k▲ 583%
Amounts payable17/49€281k€891k▲ 218%
Amounts payable after more than one year17€109k€56k▼ 48.2%
Financial debts170/4€109k€56k▼ 48.2%
Amounts payable within one year42/48€172k€835k▲ 385%
Current portion of amounts payable after more than one year42-€18k-
Trade debts44€100k€420k▲ 318%
Suppliers440/4€100k€420k▲ 318%
Taxes, remuneration and social security45€69k€394k▲ 474%
Taxes450/3€54k€329k▲ 507%
Remuneration and social security454/9€14k€65k▲ 352%
Other amounts payable47/48€3k€2k▼ 22.4%
Line20242025Change
Profit (loss) for the period9904€58k€338k▲ 483%
+ Depreciation and write-downs630€2k€20k▲ 910%
Operating cash flow (approximation)€60k€358k▲ 497%
Investment in fixed assets (approximation)-€-129k-
Change in cash-€227k-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

More with these figures Sector benchmark What changed Value indication

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
30-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Equity above €200kEq €405k ▲505%
2 profitable years in a row build equity to €405k.
25-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts

We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
1,574 m²
Building footprint
1,579 m²
Volume, LiDAR
46,471 m³
Parcel 21807G0135/00T003, Brussels · tallest building 46.6 m, ±13 floors. Linked by address, not a title deed.
284 companies at this address See who is registered here
1 establishment unit
QUALIFY Life Sciences
Louizalaan 251, 1050 BrusselComputer programming, consultancy and related activities
since 20242.355.345.387
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21807G0135/00T003 Brussels 1,574 m² 1 · 1,579 m² 46.6 m · 13 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 82,632 companies in sector 70200 we hold annual accounts for 52,575. 36,300 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded10-01-2024
Fiscal year end31-12
Abbreviation FR QLS
Activities, NACEBEL 2025
70200Business and other management consultancy

Scores and ratios are computed by Checked and are not a credit decision.